Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax: 2010-2019

Historic Long-Term Deferred Tax for Cumberland Pharmaceuticals (CPIX) over the last 10 years, with Dec 2019 value amounting to $21,802.

  • Cumberland Pharmaceuticals' Long-Term Deferred Tax fell 50.00% to $21,802 in Q3 2020 from the same period last year, while for Sep 2020 it was $21,802, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $21,802 for FY2019, which is 75.00% down from last year.
  • Cumberland Pharmaceuticals' Long-Term Deferred Tax amounted to $21,802 in FY2019, which was down 75.00% from $87,210 recorded in FY2018.
  • Cumberland Pharmaceuticals' Long-Term Deferred Tax's 5-year high stood at $3.7 million during FY2015, with a 5-year trough of $21,802 in FY2019.
  • In the last 3 years, Cumberland Pharmaceuticals' Long-Term Deferred Tax had a median value of $87,210 in 2018 and averaged $65,407.
  • Data for Cumberland Pharmaceuticals' Long-Term Deferred Tax shows a maximum YoY tumbled of 97.20% (in 2017) over the last 5 years.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Long-Term Deferred Tax stood at $3.7 million in 2015, then fell by 16.57% to $3.1 million in 2016, then crashed by 97.20% to $87,210 in 2017, then remained steady at $87,210 in 2018, then tumbled by 75.00% to $21,802 in 2019.